Flex Ltd vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Flex Ltd trades at $116.85 (market cap $44.09B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.5 (market cap $6.04B). The key difference: Flex Ltd is far larger — about 7.3× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 3 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FLEX | IOVA | |
|---|---|---|
Market Cap | $44.09B | $6.04B |
Volume | 3,022,166 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $162.07 | $14.82 |
52-Week Low | $54.51 | $1.81 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $47.18B | $5.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →